Of note, there is a discrepancy between different organs regarding how this modulation of galectin-1 should be performed, as it appears that lower levels may be beneficial in weight loss and the treatment of retinopathy, while higher galectin-1 levels may be beneficial for the kidneys and for stimulation of insulin secretion. This evidence concerns the gene LGALS1 and retinal disorder.